Sachiaki Ibe
Chief Executive Officer at ZERIA PHARMACEUTICAL CO., LTD.
Net worth: 21 M $ as of 2024-06-29
Sachiaki Ibe active positions
Companies | Position | Start | End |
---|---|---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Chairman | 2014-06-26 | - |
Chief Executive Officer | 2014-06-26 | - | |
Director/Board Member | 1972-02-29 | 2014-05-31 | |
President | 1982-03-31 | 2014-05-31 | |
Sales & Marketing | 1994-10-31 | 1996-02-29 | |
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Chairman | 2011-07-04 | - |
Career history of Sachiaki Ibe
Statistics
International
Japan | 2 |
Switzerland | 2 |
Operational
Chairman | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Sachiaki Ibe
- Experience